rs3024998

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_003376.6(VEGFA):​c.855+175C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.319 in 694,248 control chromosomes in the GnomAD database, including 36,382 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.32 ( 7816 hom., cov: 31)
Exomes 𝑓: 0.32 ( 28566 hom. )

Consequence

VEGFA
NM_003376.6 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.107

Publications

13 publications found
Variant links:
Genes affected
VEGFA (HGNC:12680): (vascular endothelial growth factor A) This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. The levels of VEGF are increased during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), thus promoting inflammation by facilitating recruitment of inflammatory cells, and by increasing the level of angiopoietin II (Ang II), one of two products of the SARS-CoV-2 binding target, angiotensin-converting enzyme 2 (ACE2). In turn, Ang II facilitates the elevation of VEGF, thus forming a vicious cycle in the release of inflammatory cytokines. [provided by RefSeq, Jun 2020]
VEGFA Gene-Disease associations (from GenCC):
  • congenital heart disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 6-43777840-C-T is Benign according to our data. Variant chr6-43777840-C-T is described in ClinVar as Benign. ClinVar VariationId is 1285895.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.401 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003376.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VEGFA
NM_003376.6
MANE Select
c.855+175C>T
intron
N/ANP_003367.4
VEGFA
NM_001025366.3
c.855+175C>T
intron
N/ANP_001020537.2P15692-14
VEGFA
NM_001025367.3
c.855+175C>T
intron
N/ANP_001020538.2P15692-16

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VEGFA
ENST00000672860.3
MANE Select
c.855+175C>T
intron
N/AENSP00000500082.3P15692-13
VEGFA
ENST00000372055.9
TSL:1
c.855+175C>T
intron
N/AENSP00000361125.5P15692-14
VEGFA
ENST00000425836.9
TSL:1
c.855+175C>T
intron
N/AENSP00000388465.4A0A0A0MSH5

Frequencies

GnomAD3 genomes
AF:
0.320
AC:
48524
AN:
151792
Hom.:
7811
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.331
Gnomad AMI
AF:
0.210
Gnomad AMR
AF:
0.343
Gnomad ASJ
AF:
0.415
Gnomad EAS
AF:
0.416
Gnomad SAS
AF:
0.271
Gnomad FIN
AF:
0.230
Gnomad MID
AF:
0.369
Gnomad NFE
AF:
0.313
Gnomad OTH
AF:
0.347
GnomAD4 exome
AF:
0.319
AC:
172932
AN:
542338
Hom.:
28566
Cov.:
7
AF XY:
0.317
AC XY:
89471
AN XY:
282230
show subpopulations
African (AFR)
AF:
0.335
AC:
4775
AN:
14256
American (AMR)
AF:
0.345
AC:
6905
AN:
20016
Ashkenazi Jewish (ASJ)
AF:
0.425
AC:
6067
AN:
14268
East Asian (EAS)
AF:
0.440
AC:
13830
AN:
31446
South Asian (SAS)
AF:
0.274
AC:
13066
AN:
47758
European-Finnish (FIN)
AF:
0.235
AC:
7008
AN:
29792
Middle Eastern (MID)
AF:
0.382
AC:
1439
AN:
3766
European-Non Finnish (NFE)
AF:
0.314
AC:
110416
AN:
351844
Other (OTH)
AF:
0.323
AC:
9426
AN:
29192
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
6046
12093
18139
24186
30232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1576
3152
4728
6304
7880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.320
AC:
48543
AN:
151910
Hom.:
7816
Cov.:
31
AF XY:
0.315
AC XY:
23397
AN XY:
74232
show subpopulations
African (AFR)
AF:
0.331
AC:
13705
AN:
41412
American (AMR)
AF:
0.343
AC:
5237
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.415
AC:
1440
AN:
3468
East Asian (EAS)
AF:
0.416
AC:
2139
AN:
5140
South Asian (SAS)
AF:
0.271
AC:
1303
AN:
4810
European-Finnish (FIN)
AF:
0.230
AC:
2431
AN:
10560
Middle Eastern (MID)
AF:
0.373
AC:
109
AN:
292
European-Non Finnish (NFE)
AF:
0.313
AC:
21251
AN:
67926
Other (OTH)
AF:
0.349
AC:
737
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1680
3359
5039
6718
8398
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
482
964
1446
1928
2410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.306
Hom.:
1111
Bravo
AF:
0.336
Asia WGS
AF:
0.302
AC:
1049
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
9.3
DANN
Benign
0.65
PhyloP100
0.11
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3024998; hg19: chr6-43745577; COSMIC: COSV57879506; COSMIC: COSV57879506; API